Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Stem Cells. Oct 26, 2021; 13(10): 1530-1548
Published online Oct 26, 2021. doi: 10.4252/wjsc.v13.i10.1530
Published online Oct 26, 2021. doi: 10.4252/wjsc.v13.i10.1530
Overview of nutritional approach in hematopoietic stem cell trans
Gamze Akbulut, Ozge Yesildemir, Department of Nutrition and Dietetics, Gazi University, Faculty of Health Sciences, Ankara 06490, Turkey
Author contributions: Akbulut G and Yesildemir O designed of the work, drafted the article; Yesildemir O took responsibility for scanning an extensive literature; Akbulut G re-evaluated the study after reporting; all authors approved final version to be published.
Conflict-of-interest statement: Authors declare no conflict of interests for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Gamze Akbulut, PhD, Professor, Department of Nutrition and Dietetics, Gazi University, Faculty of Health Sciences, Emek Mahallesi Bişkek Cad. 6. Cad. (eski 81. sokak) No. 2, Ankara 06490, Turkey. gakbulut@gazi.edu.tr
Received: January 4, 2021
Peer-review started: January 4, 2021
First decision: July 18, 2021
Revised: July 27, 2021
Accepted: August 30, 2021
Article in press: August 30, 2021
Published online: October 26, 2021
Processing time: 294 Days and 16.9 Hours
Peer-review started: January 4, 2021
First decision: July 18, 2021
Revised: July 27, 2021
Accepted: August 30, 2021
Article in press: August 30, 2021
Published online: October 26, 2021
Processing time: 294 Days and 16.9 Hours
Core Tip
Core tip: Hematopoietic stem cell transplantation (HSCT) is a high-risk procedure due to the presence of initial hematological malignancies and the high risk of complications. The novelty of the coronavirus disease 2019 (COVID-19), lack of literature and lack of antiviral agents leads to more uncertainty and an increased risk in HSCT procedures. It is important to protect HSCT patients from COVID-19 infection. Malnutrition is another important problem in HSCT patients. A proper nutritional approach is important in all phases of the HSCT procedure. Therefore, professional intervention with multidisciplinary nutrition support teams is indispensable.